Sage Therapeutics (SAGE) PT Lowered to $83 at Morgan Stanley
Tweet
Share
E-mailGet Alerts SAGE Hot Sheet
Price: $8.68 --0%
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on Sage Therapeutics (NASDAQ: SAGE) to $83.00 (from $85.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Macquarie Upgrades Merdeka Gold Resources (EMAS:IJ) to Neutral
- Huntsman (HUN) PT Lowered to $11 at Jefferies
- Larsen & Toubro Ltd. (LT:IN) (LTOUF) PT Lowered to INR4,710 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
